Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson's disease: Insights from non-human primate studies.
Saved in:
| Title: | Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson's disease: Insights from non-human primate studies. |
|---|---|
| Authors: | Emborg ME; Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center, University of Wisconsin-Madison, USA; Department of Medical Physics, University of Wisconsin-Madison, USA; Cellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, USA. Electronic address: emborg@primate.wisc.edu., Metzger JM; Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center, University of Wisconsin-Madison, USA., D'Amour K; Stemson Therapeutics, San Diego, CA, USA., Colwell JC; Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center, University of Wisconsin-Madison, USA; Cellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, USA., Neumann LC; Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center, University of Wisconsin-Madison, USA., Zhang A; Genentech, South San Francisco, CA, USA., Federoff HJ; Kenai Therapeutics, San Diego, CA, USA; Georgetown University Medical Center, Washington, DC, USA. |
| Source: | Brain research bulletin [Brain Res Bull] 2025 May; Vol. 224, pp. 111297. Date of Electronic Publication: 2025 Mar 12. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 7605818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2747 (Electronic) Linking ISSN: 03619230 NLM ISO Abbreviation: Brain Res Bull Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
